Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma

Christine Mehner, Erin Miller, Davitte Khauv, Aziza Nassar, Ann L Oberg, William R. Bamlet, Lizhi Zhang, Jens Waldmann, Evette S Radisky, Howard C. Crawford, Derek C Radisky

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDA) arises at the convergence of genetic alterations in KRAS with a fostering microenvironment shaped by immune cell influx and fibrotic changes; identification of the earliest tumorigenic molecular mediators evokes the proverbial chicken and egg problem. Matrix metalloproteinases (MMP) are key drivers of tumor progression that originate primarily from stromal cells activated by the developing tumor. Here, MMP3, known to be expressed in PDA, was found to be associated with expression of Rac1b, a tumorigenic splice isoform of Rac1, in all stages of pancreatic cancer. Using a large cohort of human PDA tissue biopsies specimens, both MMP3 and Rac1b are expressed in PDA cells, that the expression levels of the two markers are highly correlated, and that the subcellular distribution of Rac1b in PDA is significantly associated with patient outcome. Using transgenic mouse models, coexpression of MMP3 with activated KRAS in pancreatic acinar cells stimulates metaplasia and immune cell infiltration, priming the stromal microenvironment for early tumor development. Finally, exposure of cultured pancreatic cancer cells to recombinant MMP3 stimulates expression of Rac1b, increases cellular invasiveness, and activation of tumorigenic transcriptional profiles. Implications: MMP3 acts as a coconspirator of oncogenic KRAS in pancreatic cancer tumorigenesis and progression, both through Rac1b-mediated phenotypic control of pancreatic cancer cells themselves, and by giving rise to the tumorigenic microenvironment; these findings also point to inhibition of this pathway as a potential therapeutic strategy for pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)1430-1439
Number of pages10
JournalMolecular Cancer Research
Volume12
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Pancreatic Neoplasms
Adenocarcinoma
Neoplasms
Foster Home Care
Tumor Microenvironment
Acinar Cells
Metaplasia
Stromal Cells
Matrix Metalloproteinases
Transgenic Mice
Transcriptional Activation
Ovum
Chickens
Protein Isoforms
Carcinogenesis
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma. / Mehner, Christine; Miller, Erin; Khauv, Davitte; Nassar, Aziza; Oberg, Ann L; Bamlet, William R.; Zhang, Lizhi; Waldmann, Jens; Radisky, Evette S; Crawford, Howard C.; Radisky, Derek C.

In: Molecular Cancer Research, Vol. 12, No. 10, 01.10.2014, p. 1430-1439.

Research output: Contribution to journalArticle

Mehner, Christine ; Miller, Erin ; Khauv, Davitte ; Nassar, Aziza ; Oberg, Ann L ; Bamlet, William R. ; Zhang, Lizhi ; Waldmann, Jens ; Radisky, Evette S ; Crawford, Howard C. ; Radisky, Derek C. / Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma. In: Molecular Cancer Research. 2014 ; Vol. 12, No. 10. pp. 1430-1439.
@article{58b158a8dba04b729a5c54b667795cd7,
title = "Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma",
abstract = "Pancreatic ductal adenocarcinoma (PDA) arises at the convergence of genetic alterations in KRAS with a fostering microenvironment shaped by immune cell influx and fibrotic changes; identification of the earliest tumorigenic molecular mediators evokes the proverbial chicken and egg problem. Matrix metalloproteinases (MMP) are key drivers of tumor progression that originate primarily from stromal cells activated by the developing tumor. Here, MMP3, known to be expressed in PDA, was found to be associated with expression of Rac1b, a tumorigenic splice isoform of Rac1, in all stages of pancreatic cancer. Using a large cohort of human PDA tissue biopsies specimens, both MMP3 and Rac1b are expressed in PDA cells, that the expression levels of the two markers are highly correlated, and that the subcellular distribution of Rac1b in PDA is significantly associated with patient outcome. Using transgenic mouse models, coexpression of MMP3 with activated KRAS in pancreatic acinar cells stimulates metaplasia and immune cell infiltration, priming the stromal microenvironment for early tumor development. Finally, exposure of cultured pancreatic cancer cells to recombinant MMP3 stimulates expression of Rac1b, increases cellular invasiveness, and activation of tumorigenic transcriptional profiles. Implications: MMP3 acts as a coconspirator of oncogenic KRAS in pancreatic cancer tumorigenesis and progression, both through Rac1b-mediated phenotypic control of pancreatic cancer cells themselves, and by giving rise to the tumorigenic microenvironment; these findings also point to inhibition of this pathway as a potential therapeutic strategy for pancreatic cancer.",
author = "Christine Mehner and Erin Miller and Davitte Khauv and Aziza Nassar and Oberg, {Ann L} and Bamlet, {William R.} and Lizhi Zhang and Jens Waldmann and Radisky, {Evette S} and Crawford, {Howard C.} and Radisky, {Derek C}",
year = "2014",
month = "10",
day = "1",
doi = "10.1158/1541-7786.MCR-13-0557-T",
language = "English (US)",
volume = "12",
pages = "1430--1439",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma

AU - Mehner, Christine

AU - Miller, Erin

AU - Khauv, Davitte

AU - Nassar, Aziza

AU - Oberg, Ann L

AU - Bamlet, William R.

AU - Zhang, Lizhi

AU - Waldmann, Jens

AU - Radisky, Evette S

AU - Crawford, Howard C.

AU - Radisky, Derek C

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Pancreatic ductal adenocarcinoma (PDA) arises at the convergence of genetic alterations in KRAS with a fostering microenvironment shaped by immune cell influx and fibrotic changes; identification of the earliest tumorigenic molecular mediators evokes the proverbial chicken and egg problem. Matrix metalloproteinases (MMP) are key drivers of tumor progression that originate primarily from stromal cells activated by the developing tumor. Here, MMP3, known to be expressed in PDA, was found to be associated with expression of Rac1b, a tumorigenic splice isoform of Rac1, in all stages of pancreatic cancer. Using a large cohort of human PDA tissue biopsies specimens, both MMP3 and Rac1b are expressed in PDA cells, that the expression levels of the two markers are highly correlated, and that the subcellular distribution of Rac1b in PDA is significantly associated with patient outcome. Using transgenic mouse models, coexpression of MMP3 with activated KRAS in pancreatic acinar cells stimulates metaplasia and immune cell infiltration, priming the stromal microenvironment for early tumor development. Finally, exposure of cultured pancreatic cancer cells to recombinant MMP3 stimulates expression of Rac1b, increases cellular invasiveness, and activation of tumorigenic transcriptional profiles. Implications: MMP3 acts as a coconspirator of oncogenic KRAS in pancreatic cancer tumorigenesis and progression, both through Rac1b-mediated phenotypic control of pancreatic cancer cells themselves, and by giving rise to the tumorigenic microenvironment; these findings also point to inhibition of this pathway as a potential therapeutic strategy for pancreatic cancer.

AB - Pancreatic ductal adenocarcinoma (PDA) arises at the convergence of genetic alterations in KRAS with a fostering microenvironment shaped by immune cell influx and fibrotic changes; identification of the earliest tumorigenic molecular mediators evokes the proverbial chicken and egg problem. Matrix metalloproteinases (MMP) are key drivers of tumor progression that originate primarily from stromal cells activated by the developing tumor. Here, MMP3, known to be expressed in PDA, was found to be associated with expression of Rac1b, a tumorigenic splice isoform of Rac1, in all stages of pancreatic cancer. Using a large cohort of human PDA tissue biopsies specimens, both MMP3 and Rac1b are expressed in PDA cells, that the expression levels of the two markers are highly correlated, and that the subcellular distribution of Rac1b in PDA is significantly associated with patient outcome. Using transgenic mouse models, coexpression of MMP3 with activated KRAS in pancreatic acinar cells stimulates metaplasia and immune cell infiltration, priming the stromal microenvironment for early tumor development. Finally, exposure of cultured pancreatic cancer cells to recombinant MMP3 stimulates expression of Rac1b, increases cellular invasiveness, and activation of tumorigenic transcriptional profiles. Implications: MMP3 acts as a coconspirator of oncogenic KRAS in pancreatic cancer tumorigenesis and progression, both through Rac1b-mediated phenotypic control of pancreatic cancer cells themselves, and by giving rise to the tumorigenic microenvironment; these findings also point to inhibition of this pathway as a potential therapeutic strategy for pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=84907984427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907984427&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-13-0557-T

DO - 10.1158/1541-7786.MCR-13-0557-T

M3 - Article

VL - 12

SP - 1430

EP - 1439

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 10

ER -